Products found to contain undeclared medicines
|
|
Australia: Safety advisory: Slimming Capsule - Reduce Fat |
|
The Therapeutic Goods Administration (TGA) has tested a product labelled Slimming Capsule - Reduce Fat and found that the capsules contain the undeclared substances sibutramine and phenolphthalein. Consumers are advised that the product poses a serious risk to their health and should not be taken.
Sibutramine is a prescription-only medicine (which was the active ingredient in Reductil) and it was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. Phenolphthalein is a prescription-only medicine previously marketed as an oral laxative and it was withdrawn from sale from many market in the late 1990's due to concerns over its carcinogenicity with long term use.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/slimming-capsule-reduce-fat
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Jun 13, 2017
Issued at HKT 15:00
|
|
|